BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33031305)

  • 1. Impact of intraoperative allogenic and autologous transfusion on immune function and prognosis in patients with hepatocellular carcinoma.
    Gong Y; Tang Y; Xue Y; Chen L
    Medicine (Baltimore); 2020 Oct; 99(41):e22568. PubMed ID: 33031305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of allogenic and autologous transfusion on immune function in patients with tumors.
    Guo JR; Xu F; Jin XJ; Shen HC; Liu Y; Zhang YW; Shao Y
    Asian Pac J Cancer Prev; 2014; 15(1):467-74. PubMed ID: 24528076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of perioperative autologous versus allogeneic blood transfusion on the immune system in gastric cancer patients.
    Chen G; Zhang FJ; Gong M; Yan M
    J Zhejiang Univ Sci B; 2007 Aug; 8(8):560-5. PubMed ID: 17657857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Identification of immunological effector cells after autologous cytokine-induced killer cells treatment and its clinical implication in hepatocellular carcinoma patients].
    Shi M; Zhang B; Tang ZR; Lei ZY; Wang HF; Feng YY; Liu JC; Fan ZP; Li HW; Mu JS; Wang FS
    Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(23):2049-53. PubMed ID: 14703414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative blood transfusion in hepatocellular carcinomas: influence of immunologic profile and recurrence free survival.
    Kwon AH; Matsui Y; Kamiyama Y
    Cancer; 2001 Feb; 91(4):771-8. PubMed ID: 11241245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis and postoperative lymphocyte count in patients with hepatocellular carcinoma who received intraoperative allogenic blood transfusion: a retrospective study.
    Sugita S; Sasaki A; Iwaki K; Uchida H; Kai S; Shibata K; Ohta M; Kitano S
    Eur J Surg Oncol; 2008 Mar; 34(3):339-45. PubMed ID: 17400417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of perioperative blood transfusion on immune function and prognosis in colorectal cancer patients.
    Qiu L; Wang DR; Zhang XY; Gao S; Li XX; Sun GP; Lu XB
    Transfus Apher Sci; 2016 Apr; 54(2):235-41. PubMed ID: 26780991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Different Blood Transfusion Methods in Patients Undergoing Cesarean Section.
    Guo F; Tang H; Wei X
    Front Surg; 2022; 9():844984. PubMed ID: 35273999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous cytokine-induced killer cell therapy in clinical trial phase I is safe in patients with primary hepatocellular carcinoma.
    Shi M; Zhang B; Tang ZR; Lei ZY; Wang HF; Feng YY; Fan ZP; Xu DP; Wang FS
    World J Gastroenterol; 2004 Apr; 10(8):1146-51. PubMed ID: 15069715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of perioperative allogeneic blood transfusion on the long-term prognosis of patients with different stage tumors after radical resection for hepatocellular carcinoma.
    Peng T; Wang L; Cui H; Li X; Liu M; Yu J; Wu J; Zhao G; Liu Z
    Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):620-627. PubMed ID: 32988700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum alpha-fetoprotein measurement in predicting clinical outcome related to autologous cytokine-induced killer cells in patients with hepatocellular carcinoma undergone minimally invasive therapy.
    Pan CC; Huang ZL; Li W; Zhao M; Zhou QM; Xia JC; Wu PH
    Chin J Cancer; 2010 Jun; 29(6):596-602. PubMed ID: 20507732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Transcatheter Arterial Chemoembolization Combined with Argon-Helium Cryosurgery System on the Changes of NK Cells and T Cell Subsets in Peripheral Blood of Hepatocellular Carcinoma Patients.
    Huang M; Wang X; Bin H
    Cell Biochem Biophys; 2015 Dec; 73(3):787-92. PubMed ID: 27259326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological responses against an autologous human hepatocellular carcinoma cell line.
    Usuda S; Yoshizawa K; Yabu K; Kiyosawa K
    J Gastroenterol Hepatol; 1993; 8(6):517-23. PubMed ID: 8280838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of autologous blood transfusion and allogeneic blood transfusion in surgical patients.
    Long MY; Liu ZH; Zhu JG
    Int J Clin Exp Med; 2014; 7(9):2889-94. PubMed ID: 25356154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation analysis of peripheral blood T cell subgroups, immunoglobulin and prognosis of early hepatocellular carcinoma after hepatectomy.
    Che YQ; Feng L; Rong WQ; Shen D; Wang Q; Yang L; Qi J; Huang CZ
    Int J Clin Exp Med; 2014; 7(11):4282-90. PubMed ID: 25550943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC.
    Gabrielson A; Wu Y; Wang H; Jiang J; Kallakury B; Gatalica Z; Reddy S; Kleiner D; Fishbein T; Johnson L; Island E; Satoskar R; Banovac F; Jha R; Kachhela J; Feng P; Zhang T; Tesfaye A; Prins P; Loffredo C; Marshall J; Weiner L; Atkins M; He AR
    Cancer Immunol Res; 2016 May; 4(5):419-30. PubMed ID: 26968206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative analgesia with parecoxib sodium improves postoperative pain and immune function in patients undergoing hepatectomy for hepatocellular carcinoma.
    Wang RD; Zhu JY; Zhu Y; Ge YS; Xu GL; Jia WD
    J Eval Clin Pract; 2020 Jun; 26(3):992-1000. PubMed ID: 31407484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes of T Lymphocyte Subsets and Immunoglobulin in Peripheral Blood of Patients with ALL and N-ALL before and after Treatment and their Value for Monitoring of Disease and Evaluation of Prognosis].
    Zhu QY; Dian ZJ; Zhou YG; Zhao Z; Zhang Z; Zhang XY; Yang BR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Feb; 26(1):136-140. PubMed ID: 29397832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Short-term curative efficacy of cytokine-induced killer cells combined micro-invasive treatments on hepatocellular carcinoma].
    Zhou QM; Wu PH; Zhao M; Wang QJ; Huang LX; Li YQ; Chen SP; Xia JC
    Ai Zheng; 2006 Nov; 25(11):1414-8. PubMed ID: 17094912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.